Mucosal healing in pediatric Crohn's disease: the goal of medical treatment

Inflamm Bowel Dis. 2004 Jul;10(4):479-80. doi: 10.1097/00054725-200407000-00024.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Age Factors
  • Antibodies, Monoclonal / therapeutic use*
  • Azathioprine / therapeutic use*
  • Child
  • Crohn Disease / drug therapy*
  • Crohn Disease / pathology*
  • Disease Progression
  • Drug Resistance
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Intestinal Mucosa / pathology*
  • Quality of Life
  • Tumor Necrosis Factor-alpha

Substances

  • Antibodies, Monoclonal
  • Gastrointestinal Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Azathioprine